Trademark: 78733131
Status Date
Thursday, September 23, 2010
Filing Date
Friday, October 14, 2005
Published for Opposition
Tuesday, December 4, 2007
Abandoned Date
Tuesday, August 24, 2010
5 Biological preparations for medical purposes; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for treatment of anaphylactic reactions; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations acting on the peripheral system; Pharmaceutical preparations for pain management; Pharmaceutical preparations of immune diseases; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in radiation therapy to treat cancer; Pharmaceutical preparations for wounds; Pharmaceutical preparations namely, anticoagulants; Pharmaceutical preparations for the treatement of depression, anxiety, stress, and related affective diseases and disorders; Pharmaceutical preparations namely,appetite suppressants; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Synthetic peptides for pharmaceutical purposes
42 Conducting early evaluations in the field of new pharmaceuticals; Development of new technology for others in the field of biopharmaceuticals; Development of pharmaceutical preparations and medicines; Medical and scientific research services in the field of cancer treatment and diagnosis; Medical and scientific research, namely conducting clinical trials; Medical research; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Research on the subject of pharmaceuticals; Scientific investigations for medical purposes; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff
Sep 23, 2010
Abandonment Notice Mailed - Failure To Respond
Sep 23, 2010
Abandonment - Failure To Respond Or Late Response
Feb 23, 2010
Notification Of Subsequent Final Emailed
Feb 23, 2010
Continuation Of Final Refusal E-Mailed
Feb 23, 2010
Su - Action Continuing Final - Written
Feb 20, 2010
Petition To Revive-Granted
Feb 20, 2010
Teas Petition To Revive Received
Jan 8, 2010
Abandonment Notice Mailed - Defective Use Statement
Jan 8, 2010
Abandonment - Defective Use Statement
Jun 2, 2009
Notification Of Final Refusal Emailed
Jun 2, 2009
Final Refusal E-Mailed
Jun 2, 2009
Su - Final Refusal - Written
May 27, 2009
Teas/Email Correspondence Entered
May 27, 2009
Correspondence Received In Law Office
May 25, 2009
Teas Response To Office Action Received
Jan 28, 2009
Notification Of Non-Final Action E-Mailed
Jan 28, 2009
Non-Final Action E-Mailed
Jan 28, 2009
Su - Non-Final Action - Written
Jan 27, 2009
Statement Of Use Processing Complete
Jan 23, 2009
Use Amendment Filed
Jan 23, 2009
Teas Statement Of Use Received
Dec 9, 2008
Noa Mailed - Sou Required From Applicant
Oct 30, 2008
New Noa To Issue
Aug 26, 2008
Notice Of Allowance Cancelled
Oct 30, 2008
Case Assigned To Intent To Use Paralegal
Oct 30, 2008
Petition To Revive-Granted
Oct 30, 2008
Teas Petition To Revive Received
Oct 27, 2008
Abandonment Notice Mailed - No Use Statement Filed
Oct 27, 2008
Abandonment - No Use Statement Filed
Feb 26, 2008
Noa Mailed - Sou Required From Applicant
Dec 4, 2007
Published For Opposition
Nov 14, 2007
Notice Of Publication
Oct 12, 2007
Withdrawn From Pub - Og Review Query
Oct 2, 2007
Law Office Publication Review Completed
Oct 2, 2007
Assigned To Lie
Aug 31, 2007
Approved For Pub - Principal Register
Aug 29, 2007
Teas/Email Correspondence Entered
Aug 29, 2007
Correspondence Received In Law Office
Aug 29, 2007
Teas Response To Office Action Received
Apr 26, 2007
Non-Final Action E-Mailed
Apr 26, 2007
Non-Final Action Written
Apr 11, 2007
Petition To Revive-Granted
Apr 11, 2007
Teas Petition To Revive Received
Mar 29, 2007
Abandonment Notice Mailed - Failure To Respond
Mar 28, 2007
Abandonment - Failure To Respond Or Late Response
Aug 28, 2006
Non-Final Action E-Mailed
Aug 28, 2006
Non-Final Action Written
Aug 18, 2006
Teas/Email Correspondence Entered
Aug 16, 2006
Correspondence Received In Law Office
Aug 16, 2006
Teas Response To Office Action Received
Apr 25, 2006
Non-Final Action E-Mailed
Apr 25, 2006
Non-Final Action Written
Apr 19, 2006
Assigned To Examiner
Oct 20, 2005
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
